81206 Bcr/abl1 gene major bp
Pathology & Lab
Also known as: BCR-ABL major breakpoint, BCR-ABL p210 testing
Molecular analysis to detect BCR-ABL1 fusion with major breakpoint (p210 fusion protein) in chronic myeloid leukemia.
Clinical Context
Used to confirm chronic phase chronic myeloid leukemia diagnosis and guide tyrosine kinase inhibitor selection and monitoring.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.